• Study Finds Elevated Risk Of Eye Inflammatory Disorder Following COVID-19 Vaccination

    Study Finds Elevated Risk Of Eye Inflammatory Disorder Following COVID-19 Vaccination Authored by Megan Redshaw, J.D. via The Epoch Times (emphasis ours), People with a history of uveitis may experience a recurrence of the eye inflammatory disorder following COVID-19 vaccination, especially in the early postvaccination period. (MicroScience/Shutterstock) A recently published study in JAMA Ophthalmology found that about 17 percent of nearly 474,000 vaccinated individuals with a...

  • AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases

    AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect remains unknown.

  • AstraZeneca vindicates skeptics with admission that its COVID-19 vaccine can cause blood clots

    The British-Swedish pharmaceutical giant AstraZeneca has finally admitted that its COVID-19 vaccine can cause bloodclots. While there were plenty of indications and fatalities over the years to suggest as much, the company and so-called experts around the world long downplayed the causal link along with critics' concerns. Clot shot The Oxford-AstraZeneca COVID-19 vaccine was a viral vector vaccine developed in the United Kingdom, which used a transmogrified version of a chimpanzee...

  • European Medicines Agency says modified Covid vaccine needed to combat new variant

    A new variant of the coronavirus has become dominant, supplanting other versions of the virus. This is why the Emergency Task Force of the European Medicines Agency (EMA) in Amsterdam issued a statement on Tuesday advising that the Covid-19 vaccine be adapted ahead of vaccination campaigns organized by EU Member States this year and next, beginning with vaccination rounds in the autumn.

  • In a first, AstraZeneca admits its Covid vaccine Covishield can cause rare side effects

    AstraZeneca, for the first time, admitted in its court documents that its Covid vaccine can cause rare side effects, paving way for a multi-million pound legal payout, The Telegraph reported on Sunday. The pharmaceutical company is being sued in a class action over claims that its vaccine against Covid-19, developed with the University of Oxford, caused death and serious injury, including TTS — Thrombosis with Thrombocytopenia Syndrome — which causes people to have blood clots and a low blood...

  • AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?

    Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. The admission was made in a legal document submitted to the High Court in February.The company stated in the document that TTS can happen even if there is no vaccination, adding that expert testimony will be required to determine causation in every individual case.AstraZeneca has been fighting a class action lawsuit that alleges its Covid vaccine, which was developed with...

  • COVID-19 Vaccine Protection Among Children Plummets Within Months: CDC Study

    COVID-19 Vaccine Protection Among Children Plummets Within Months: CDC Study Authored by Zachary Stieber via The Epoch Times, Children who received an original COVID-19 vaccine have little protection against hospitalization just months after vaccination, according to a new study from the U.S. Centers for Disease Control and Prevention (CDC). Children initially have 52 percent protection against hospitalization but that estimated effectiveness plummeted to 19 percent after four...

  • In a First, AstraZeneca Acknowledges Rare Blood Clot Risk in COVID-19 Vaccine | Weather.com

    In India, where Covishield constitutes a significant portion of the national vaccination drive, the admission has prompted discussions about vaccine safety and public confidence. - Articles from The Weather Channel | weather.com

  • AstraZeneca acknowledges covid vaccine can lead to rare side effect TSS in court; Here's what we know

    UK pharmaceutical giant AstraZeneca has acknowledged that its Covid-19 vaccine can lead to a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). This admission comes as the company faces a lawsuit alleging severe harm and deaths caused by the vaccine, according to The Telegraph.TTS is thrombosis with thrombocytopenia syndrome, which is basically a clot in blood vessels of the brain or elsewhere, along with a low platelet count. It is known to occur in very rare instances...

  • AstraZeneca admits in court that its 'Covid vaccine can cause TTS side effects in rare cases'

    NEW DELHI: UK Pharmaceutical company AstraZeneca has admitted that its Covid-19 vaccine has the potential to cause to a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS), as reported by The Telegraph.AstraZeneca which collaborated with the University of Oxford to create the vaccine is currently dealing with a lawsuit that claims their vaccine has caused deaths and severe harm to those who received it.Previous year, Jamie Scott, a father of two, took legal action after...

    • mint

    AstraZeneca admits its Covid vaccine 'can cause TTS in very rare cases'. All you need to know | Mint

    Pharmaceutical giant AstraZeneca has admitted that its Covid-19 vaccine can cause a rare side effect known as Thrombosis with Thrombocytopenia Syndrome' (TTS), according to a report by the London-based newspaper The Telegraph. The admission was made in court documents for the first time since rolling out of the vaccine.The pharmaceutical company, which developed the vaccine in partnership with the University of Oxford, is facing a class-action lawsuit alleging that their vaccine has resulted in...

  • AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time

    Pharmaceutical giant being sued in class action over claims its vaccine